GB672510A - Improvements in or relating to the purification of aureomycin - Google Patents

Improvements in or relating to the purification of aureomycin

Info

Publication number
GB672510A
GB672510A GB18130/50A GB1813050A GB672510A GB 672510 A GB672510 A GB 672510A GB 18130/50 A GB18130/50 A GB 18130/50A GB 1813050 A GB1813050 A GB 1813050A GB 672510 A GB672510 A GB 672510A
Authority
GB
United Kingdom
Prior art keywords
aureomycin
mash
alcohol
extract
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB18130/50A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB672510A publication Critical patent/GB672510A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Aureomycin in the form of an acid salt is isolated from an aqueous aureomycin solution, having a pH of less than 4 and containing at least 0.3 mg. of aureomycin per ml., by adding to such a solution a water-soluble inorganic salt and a mono- or poly-hydric alcohol or an ester or ether thereof as solvent for the aureomycin the amount of salt being preferably substantially sufficient to saturate said aqueous solution and the amount of organic solvent being preferably insufficient to appreciably dissolve or extract the aureomycin, and separating the resulting acid salt of aureomycin. It is preferred that the aureomycin concentration be 0.3 to 30 mg. per ml., the pH between 1 and 4 and the organic solvent butanol in the proportions of not more than 10 per cent, and preferably 5 per cent, by volume. The aureomycin solution may be prepared from the fermentation mash of Streptomyces aureofaciens or other aureomycin producing organism by: (a) acidifying the mash with mineral acid to a pH below 4, adding a filtration aid, e.g. fuller's earth, filtering and evaporating the filtrate in vacuo below 50 DEG C. and preferably between 20 DEG and 40 DEG C.; (b) treating the mash with calcium, strontium, barium or magnesium ions at a pH 6 to 11, and preferably 7 to 9, adding fuller's earth and filtering, the cake so formed being extracted with mineral acid and the extract concentrated as in (a); and (c) extracting the mash with a water-miscible organic solvent containing mineral acid, e.g. ketones, such as acetone and aliphatic alcohols such as ethanol, removing the solvent from the extract and concentrating the extract as in (a). The organic solvents for the aureomycin which are used in the formation of the acid salts may be anhydrous ethanol, methanol, isopropanol, b -ethoxyethanol, n-butanol, sec.-butanol, amyl alcohol, hexyl alcohol, capryl alcohol, octyl alcohol and decanol, of which the substantially water-insoluble solvents are preferred. The inorganic salts may be sodium chloride, ammonium chloride, lithium chloride, potassium chloride, calcium chloride, sodium sulphate, ammonium sulphate, lithium sulphate, disodium hydrogen phosphate and potassium dihydrogen phosphate, of which the chlorides are preferred.
GB18130/50A 1949-08-20 1950-07-20 Improvements in or relating to the purification of aureomycin Expired GB672510A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US672510XA 1949-08-20 1949-08-20

Publications (1)

Publication Number Publication Date
GB672510A true GB672510A (en) 1952-05-21

Family

ID=22074745

Family Applications (1)

Application Number Title Priority Date Filing Date
GB18130/50A Expired GB672510A (en) 1949-08-20 1950-07-20 Improvements in or relating to the purification of aureomycin

Country Status (1)

Country Link
GB (1) GB672510A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics
CN101863797A (en) * 2010-07-07 2010-10-20 福建省福抗药业股份有限公司 New process for preparing chlortetracycline hydrochloride
CN114848599A (en) * 2022-06-09 2022-08-05 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics
CN101863797A (en) * 2010-07-07 2010-10-20 福建省福抗药业股份有限公司 New process for preparing chlortetracycline hydrochloride
CN101863797B (en) * 2010-07-07 2013-04-24 福建省福抗药业股份有限公司 New process for preparing chlortetracycline hydrochloride
CN114848599A (en) * 2022-06-09 2022-08-05 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof
CN114848599B (en) * 2022-06-09 2023-10-13 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof

Similar Documents

Publication Publication Date Title
GB672510A (en) Improvements in or relating to the purification of aureomycin
Underkofler et al. The production of dihydroxyacetone by the action of Acetobacter suboxydans upon glycerol
GB683423A (en) Improvements in and relating to antibiotic substances produced by group n streptococcus lactis
GB1404546A (en) Process for purifying commercial-grade phosphoric acid by extraction
GB1357614A (en) Purification of phosphoric acid
GB977327A (en) An antibiotic moenomycin and a process for its manufacture
US3907869A (en) Method of producing calcium pangamate
GB746534A (en) A process for the separation of monoalkyl phosphates from dialkyl phosphates
GB1412691A (en) Recovery of bacitracin
GB1472970A (en) Purfified phosphoric acid and its production
GB552619A (en) Improvements relating to bactericidal substances
GB1275345A (en) PROCESS FOR THE MANUFACTURE OF MONO-ALKALI AND DI-ALKALI METAL SALTS OF alpha-CARBOXYBENZYLPENICILLIN
GB578590A (en) Improvements in or relating to the preparation of penicillin salts
DE420910C (en) Process for the preparation of double compounds from aliphatic amino acids and inorganic alkali salts
GB1237710A (en) Process for manufacturing sodium tripolyphosphate
GB772149A (en) Production of a new antibiotic bromotetracycline by fermentation
GB1365362A (en) Process for producing cirtic acid
GB555450A (en) Process for the preparation of active glucosides of senna
US2443962A (en) Method of producing antibiotic substance
GB1018342A (en) Production of purified preparations of the kallikrein inactivator
GB770248A (en) Improvements in or relating to the preparation of bacitracin
GB822667A (en) Process for the preparation of common salt by the evaporation of solutions
GB463698A (en) Process for the manufacture of a vitamin preparation
GB678508A (en) Preparation of crystalline benzylpenicillinic acid-diisopropyl etherate
GB496248A (en) Pancreas-derived product and process of producing it